Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Calithera Biosciences's peak revenue was $26.0M in 2017. The peak quarterly revenue was $17.1M in 2018(q2).
Calithera Biosciences's revenue increased from $26.0m in 2017 to $9.8M currently. That's a -62.43% change in annual revenue.
| Fiscal year / year | Calithera Biosciences revenue |
|---|---|
| 2017 | $26.0M |
| 2018 | $22.3M |
| 2021 | $9.8M |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2017 | $4.2M | $7.3M | $7.3M | $7.3M |
| 2018 | $5.2M | $17.1M | - | - |
| 2021 | - | $3.0M | $6.8M | - |
Do you work at Calithera Biosciences?
Is Calithera Biosciences transparent about its revenue structure?
| Company Type | Public |
| Employees Number | 79 |
| Date Founded | 2010 |
| Headquarters | South San Francisco, California |
| Number of Locations | 2 |
| Revenue | $9.8M |
| Net Income | -$39,650,000 |
| PE Ratio | -5.16 |
| Market Capitalization | $204.4M |
| Total Assets | $28,676,000 |
| Ticker | CALA |
Calithera Biosciences received early financing of $40.0M on 2010-07-08.
| Series | Round size | Date |
|---|---|---|
| Series A | $40M | 07/2010 |
| Series Unknown | $4M | 11/2011 |
| Series B | $8M | 05/2012 |
| Series C | $2M | 12/2012 |
| Series D | $35M | 10/2013 |
| Series Unknown | $16.0M | 07/2014 |
| Post Ipo Equity | $80.5M | 03/2017 |
| Post Ipo Equity | $57.5M | 06/2019 |
| Post Ipo Equity | $36M | 04/2020 |
| Grant | $2.4M | 11/2020 |
| Post Ipo Equity | $10M | 03/2022 |
| Investors | Security type |
|---|---|
| Delphi Ventures | Series A |
| U.S. Venture Partners (USVP) | Series A |
| Morgenthaler Ventures | Series A |
| Mission Bay Capital | Series A |
| Advanced Technology Ventures | Series A |
| Delphi Ventures | Series Unknown |
| U.S. Venture Partners (USVP) | Series Unknown |
| Advanced Technology Ventures | Series Unknown |
| Morgenthaler Ventures | Series Unknown |
| Delphi Ventures | Series C |
| Morgenthaler Ventures | Series C |
| Advanced Technology Ventures | Series C |
| Delphi Ventures | Series D |
| Longwood Fund | Series D |
| Adage Capital Management | Series D |
| Morgenthaler Ventures | Series D |
| Advanced Technology Ventures | Series D |
| Cystic Fibrosis Foundation | Grant |
Zippia gives an in-depth look into the details of Calithera Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Calithera Biosciences. The employee data is based on information from people who have self-reported their past or current employments at Calithera Biosciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Calithera Biosciences. The data presented on this page does not represent the view of Calithera Biosciences and its employees or that of Zippia.
Calithera Biosciences may also be known as or be related to CALITHERA BIOSCIENCES INC., Calithera Biosciences, Calithera Biosciences Inc and Calithera Biosciences, Inc.